THE CLINICAL USE OF TRIETHYLENE MELAMINE

被引:32
作者
KRAVITZ, SC
DIAMOND, HD
CRAVER, LF
机构
关键词
D O I
10.1182/blood.V7.7.729.729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:729 / 742
页数:14
相关论文
共 6 条
[1]  
DAMESHEK W., 1949, BLOOD JOUR HEMATOL, V4, P338
[2]  
DIAMOND HD, 1951, CANCER-AM CANCER SOC, V4, P999, DOI 10.1002/1097-0142(195109)4:5<999::AID-CNCR2820040515>3.0.CO
[3]  
2-N
[4]   TRIETHYLENE MELAMINE IN THE TREATMENT OF NEOPLASTIC DISEASE - A COMPOUND WITH NITROGEN-MUSTARD-LIKE ACTIVITY SUITABLE FOR ORAL AND INTRAVENOUS USE [J].
KARNOFSKY, DA ;
BURCHENAL, JH ;
ARMISTEAD, GC ;
SOUTHAM, CM ;
BERNSTEIN, JL ;
CRAVER, LF ;
RHOADS, CP .
ARCHIVES OF INTERNAL MEDICINE, 1951, 87 (04) :477-516
[5]   UREMIA COMPLICATING LEUKEMIA CHEMOTHERAPY - REPORT OF A CASE TREATED WITH TRIETHYLENE MELAMINE [J].
KRAVITZ, SC ;
DIAMOND, HD ;
CRAVER, LF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1951, 146 (17) :1595-1597
[6]   TRISETHYLENEIMINO-S-TRIAZINE IN HUMAN MALIGNANT DISEASE - A PRELIMINARY TRIAL [J].
PATERSON, E ;
BOLAND, J .
BRITISH JOURNAL OF CANCER, 1951, 5 (01) :28-&